Viking Therapeutics VKTX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$18.44M (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 24.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 19.10% to 18.95% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +3,512,449 | 7.7% |
| Barclays PLC | Public Company | 2026/Q3 | +548,183 | 0.5% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +340,509 | 4.2% |
| BNY Mellon Advisors, Inc. | Mutual Fund | 2026/Q3 | +299,380 | 0.3% |
| Barclays Bank Plc | Private Company | 2026/Q3 | +271,522 | 0.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +233,650 | 3.7% |
| ACT Capital Management | Hedge Fund | 2026/Q3 | +220,200 | 0.3% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +176,278 | 0.5% |
| Quinn Opportunity Partners LLC | Hedge Fund | 2026/Q3 | +171,000 | 0.1% |
| BW Gestao de Investimentos Ltda. | Family Office/Trust | 2026/Q3 | +150,000 | 0.1% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +131,264 | 1.0% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +129,473 | 0.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,210,837 | 4.8% |
| Leap Investments LP | Mutual Fund | 2026/Q3 | +579,800 | 0.5% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +477,338 | 1.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 31 Jul 2026 | Dorothy Gemmell | Director | Other Acquisition | +6,333 | – | 6,333 |
| 31 Jul 2026 | Dorothy Gemmell | Director | Other Derivative Acquisition | +40,800 | $31.74 | 40,800 |
| 28 Jul 2026 | Gregory Zante | Chief Financial Officer | Open Market Disposition | -21,217 | $33.47 | 118,182 |
| 28 Jul 2026 | Brian Lian | Chief Executive Officer | Open Market Disposition | -148,517 | $33.32 | 2,215,508 |
| 28 Jul 2026 | Marianne Mancini | Former Chief Operating Officer | Open Market Disposition | -18,217 | $33.47 | 314,293 |
| 27 Jul 2026 | Gregory Zante | Chief Financial Officer | Other Acquisition | +31,667 | – | 118,182 |
| 27 Jul 2026 | Brian Lian | Chief Executive Officer | Other Acquisition | +221,667 | – | 2,215,508 |
| 27 Jul 2026 | Marianne Mancini | Former Chief Operating Officer | Other Acquisition | +31,667 | – | 314,293 |
| 31 May 2026 | Hubert Chen | Chief Medical Officer | Other Derivative Acquisition | +190,000 | $31.27 | 190,000 |
| 9 Mar 2026 | Neil Aubuchon | Former Chief Commercial Officer | Open Market Acquisition | +4,475 | $33.50 | 4,475 |
| 11 Jan 2026 | Neil Aubuchon | Former Chief Commercial Officer | Other Derivative Acquisition | +180,000 | $31.76 | 180,000 |
| 4 Jan 2026 | Gregory Zante | Chief Financial Officer | Other Acquisition | +41,000 | – | 94,022 |
| 4 Jan 2026 | Gregory Zante | Chief Financial Officer | Open Market Disposition | -57,661 | $34.24 | 95,869 |
| 4 Jan 2026 | Brian Lian | Chief Executive Officer | Other Acquisition | +78,400 | – | 356,933 |
| 4 Jan 2026 | Brian Lian | Chief Executive Officer | Open Market Disposition | -233,409 | $35.07 | 2,142,358 |
| 4 Jan 2026 | Marianne Mancini | Former Chief Operating Officer | Other Acquisition | +41,000 | – | 94,022 |
| 4 Jan 2026 | Marianne Mancini | Former Chief Operating Officer | Open Market Disposition | -57,661 | $35.07 | 315,168 |
| 1 Jan 2026 | Matthew Foehr | Independent Director | Other Acquisition | +3,150 | – | 3,150 |
| 1 Jan 2026 | Matthew Foehr | Independent Director | Derivative Exercise and Sale | -16,000 | $35.11 | 132,036 |
| 1 Jan 2026 | Matthew Foehr | Independent Director | Other Derivative Acquisition | +20,400 | $35.42 | 20,400 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 24,163,022 | 18.9% | 5.4 |
| 15 Oct 2026 | 25,538,849 | 20.1% | 4.4 |
| 30 Sep 2026 | 25,921,759 | 22.2% | 2.2 |
| 15 Sep 2026 | 22,583,758 | 19.4% | 12.3 |
| 31 Aug 2026 | 22,186,520 | 19.0% | 12.4 |
| 14 Aug 2026 | 22,285,459 | 19.1% | 13.3 |
No comments yet — be the first to weigh in on VKTX.
Sign in to join the discussion.